中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
6期
8-9
,共2页
温肺化瘀汤%小儿喘息性支气管炎%二重感染发生率
溫肺化瘀湯%小兒喘息性支氣管炎%二重感染髮生率
온폐화어탕%소인천식성지기관염%이중감염발생솔
Wenfeihuayutang%Pediatric asthmatic bronchitis%Double infection rate
目的：观察温肺化瘀汤治疗小儿喘息性支气管炎的疗效。方法：以2011年10月-2013年4月笔者所在医院诊断为小儿喘息性支气管炎的96例患儿作为研究对象，将其随机分为治疗组与对照组。其中，治疗组予以温肺化瘀汤治疗联合常规西医治疗，对照组予以常规西医治疗。治疗2周后观察并比较两种疗法有效率、治愈时间及二重感染发生率的差异，并评估治疗风险。结果：治疗组治愈率明显高于对照组(66.67%vs 43.75%，P<0.05)，无效率低于对照组(6.25%vs 16.67%，P<0.05)，二重感染发生率低于对照组(8.33%vs 25.00%，P<0.05)，且治疗组治愈时间短于对照组，但并未增加小儿喘息性支气管炎的治疗风险。结论：在治疗小儿喘息性支气管炎方面，温肺化瘀汤是一种安全、有效的治疗手段。
目的：觀察溫肺化瘀湯治療小兒喘息性支氣管炎的療效。方法：以2011年10月-2013年4月筆者所在醫院診斷為小兒喘息性支氣管炎的96例患兒作為研究對象，將其隨機分為治療組與對照組。其中，治療組予以溫肺化瘀湯治療聯閤常規西醫治療，對照組予以常規西醫治療。治療2週後觀察併比較兩種療法有效率、治愈時間及二重感染髮生率的差異，併評估治療風險。結果：治療組治愈率明顯高于對照組(66.67%vs 43.75%，P<0.05)，無效率低于對照組(6.25%vs 16.67%，P<0.05)，二重感染髮生率低于對照組(8.33%vs 25.00%，P<0.05)，且治療組治愈時間短于對照組，但併未增加小兒喘息性支氣管炎的治療風險。結論：在治療小兒喘息性支氣管炎方麵，溫肺化瘀湯是一種安全、有效的治療手段。
목적：관찰온폐화어탕치료소인천식성지기관염적료효。방법：이2011년10월-2013년4월필자소재의원진단위소인천식성지기관염적96례환인작위연구대상，장기수궤분위치료조여대조조。기중，치료조여이온폐화어탕치료연합상규서의치료，대조조여이상규서의치료。치료2주후관찰병비교량충요법유효솔、치유시간급이중감염발생솔적차이，병평고치료풍험。결과：치료조치유솔명현고우대조조(66.67%vs 43.75%，P<0.05)，무효솔저우대조조(6.25%vs 16.67%，P<0.05)，이중감염발생솔저우대조조(8.33%vs 25.00%，P<0.05)，차치료조치유시간단우대조조，단병미증가소인천식성지기관염적치료풍험。결론：재치료소인천식성지기관염방면，온폐화어탕시일충안전、유효적치료수단。
Objective:To observe the efficacy of Wenfeihuayutang in treatment of pediatric asthmatic bronchitis.Method:A total of 96 cases of pediatric asthmatic bronchitis diagnosed in our hospital from Oct 2011 to Apr 2013 were included in this study and randomly divided into the treatment group to receive combination therapy of Wenfeihuayutang and conventional western medicine,the control group to receive conventional western medicine only.After 2 weeks of treatment,the differences of the effective rate,time of cure and double infection rate between two groups were compared,the evaluation of treatment risk was also included.Result:The cure rate was higher in treatment group than that in control group(66.67%vs 43.75%,P<0.05),the invalid and double infection rates were lower in treatment group than that in control group(6.25%vs 16.67%,P<0.05;8.33%vs 25.00%,P<0.05).The time of cure in treatment group was shorter than that of control group(P<0.05),the treatment risk was not increased by WenfFeihuayutang.Conclusion:In treatment of pediatric asthmatic bronchitis, Wenfeihuayutang is a safety and effective therapy.
